
Michael Elman
Physician · Elman Retina Group Pa
Credentials: · · ·
History
- 2019–Present
Elman Retina Group Pa
- 1983–1984
- 1980–1983
University of Illinois Hosp. & Clini
- 1979–1980
Preliminary or Transitional Year

Research
Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema
New England Journal of Medicine · 2015 · 1,293 citations
Ophthalmology · 2010 · 1,109 citations
JAMA · 2015 · 617 citations
- AA
15 papers
- NB
15 papers

13 papers

12 papers
- EC
11 papers
- FF
10 papers

8 papers

8 papers
Grants
- 1988–1993
Maryland Biostatistics-Epidemiology-Clinical Trails Unit
National Eye Institute · R21
Contact PI · $91.2K · University of Maryland Baltimore
Clinical trials
- 2018–2019
Retrospective Review of Proliferative Diabetic Retinopathy Patients
Principal investigator · Unknown
Elman Retina Group
- 2016–2019
Identifying Patients With Unrecognized Treatable Diabetic Macular Edema
Principal investigator · Unknown
Elman Retina Group
- 2012–2014
Principal investigator · Terminated · Phase 2
Johns Hopkins University
- 2007–2014
Laser-Ranibizumab-Triamcinolone for Diabetic Macular Edema
Study chair · Completed · Phase 3
Jaeb Center for Health Research
